`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`METRICS, INC.
`Petitioner
`
`v.
`
`SENJU PHARMACEUTICAL CO., LTD.
`Patent Owner
`
`U.S. Patent No. 8,129,431 to Sawa et al.
`Issue Date: March 6, 2012
`Title: Aqueous Liquid Preparation Containing 2-Amino-3-(4-bromobenzoyl)
`Phenylacetic Acid
`
`_____________________
`
`Inter Partes Review No.: IPR2014-01041
`_____________________
`
`PETITIONER’S REVISED MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`Mail Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`DM2\5092045.1
`
`
`
`
`
`I. MANDATORY NOTICES (37 C.F.R. § 42.8(a)(1))
`
`A. Each Real Party-In-Interest (37 C.F.R. § 42.8(b)(1))--Unchanged
`
`The real parties in interest are Metrics, Inc., Mayne Pharma, and Johnson
`
`Matthey, Inc.
`
`B. Notice of Related Matters (37 C.F.R. § 42.8(b)(2))--Revised
`
`1.
`
`Judicial Matters
`
`Senju Pharmaceutical Co., Ltd., Bausch & Lomb, Inc., and Bausch & Lomb
`
`Pharma Holdings Corp. v. Lupin, Ltd. and Lupin Pharmaceuticals, Inc., C.A. No.
`
`1:14-CV-00667-JBS-KMW (D.N.J.) ; Senju Pharmaceutical Co., Ltd., Bausch &
`
`Lomb, Inc., and Bausch & Lomb Pharma Holdings Corp. v. Lupin, Ltd. and Lupin
`
`Pharmaceuticals, Inc., C.A. No. 1:14-CV-04149-JBS-KMW (D.N.J.) ; Senju
`
`Pharmaceutical Co., Ltd., Bausch & Lomb, Inc., and Bausch & Lomb Pharma
`
`Holdings Corp. v. Lupin, Ltd. and Lupin Pharmaceuticals, Inc., C.A. No. 1:14-CV-
`
`05144-JBS-KMW (D.N.J.); Senju Pharmaceutical Co., Ltd., Bausch & Lomb, Inc.,
`
`and Bausch & Lomb Pharma Holdings Corp. v. Metrics, Inc, Mayne Pharma
`
`Group Limited, Mayne Pharma (USA), Inc., and Coastal Pharmaceuticals, Inc.
`
`C.A. No. 1:14-cv-03962-JBS-KMW (D.N.J.); Senju Pharmaceutical Co., Ltd.,
`
`Bausch & Lomb, Inc., and Bausch & Lomb Pharma Holdings Corp., v. Metrics,
`
`Inc., Mayne Pharma Group Limited, Mayne Pharma (USA), Inc., and Coastal
`
`Pharmaceuticals, Inc., C.A. No. 1:14-cv-04964-JBS-KMW(D.N.J.), and Senju
`
`
`DM2\5092045.1
`
`2
`
`
`
`
`
`Pharmaceutical Co., Ltd., Bausch & Lomb, Inc., and Bausch & Lomb Pharma
`
`Holdings Corp., v. Metrics, Inc., Mayne Pharma Group Limited, Mayne Pharma
`
`(USA), Inc., and Coastal Pharmaceuticals, Inc., C.A. No. 4:14-cv-00141-BO
`
`(E.D.N.C.) which involve the ’431, ’290 patent, and/or ’131 patents.
`
`2.
`
`Administrative Matters--Unchanged
`
`Petitioner has filed concurrently with this Petition, a Petition for Inter Partes
`
`review of U.S. Patent No. 8,669,290 (“the ’290 patent”), which issued on March
`
`11, 2014 and claims priority to the application that issued as the ’431 patent.
`
`U.S. Patent No. 8,497,304, a division of the ’431 patent, issued on July 30,
`
`2013 and claims the priority to the application that issued as the ’431 patent.
`
`U.S. Patent No. 8,754,131, a division of the ’290 patent, issued on June 17,
`
`2014 and claims the priority to the application that issued as the ’431 patent.
`
`U.S. Application Serial Nos. 14/261,720 and 14/269,692 are pending and
`
`claim priority to the application which issued as the ’431 patent.
`
`C. Designation of Lead and Back-Up Counsel (37 C.F.R. §
`42.8(b)(3))--Unchanged
`
`Lead Counsel
`
`Back-Up Counsel
`
`Patrick D. McPherson (Reg. No.
`
`Vincent L. Capuano (Reg. No. 42,385 )
`
`46,255 )
`
`DUANE MORRIS LLP
`
`DUANE MORRIS LLP
`
`100 High Street, Suite 2400
`
`
`DM2\5092045.1
`
`3
`
`
`
`
`
`Lead Counsel
`
`Back-Up Counsel
`
`505 9th Street, N.W., Suite 1000
`
`Boston, MA 02110
`
`Washington, DC 20004-2166
`
`857.488.4250 (telephone)
`
`202.776.7800 (telephone)
`
`857.488.4202 (facsimile)
`
`202.776.7801 (facsimile)
`
`VCapuano@duanemorris.com
`
`PDMcPherson@duanemorris.com
`
`
`
`
`
`D. Notice of Service Information (37 C.F.R. § 42.8(b)(4))--Unchanged
`
`Please direct all correspondence to lead counsel at the above address.
`
`Petitioner consents to email service at: VCapuano@duanemorris.com and
`
`PDMcPherson@duanemorris.com.
`
`
`
` RESPECTFULLY SUBMITTED,
`DUANE MORRIS LLP
`
`Date: September 4, 2014
`
`
`
`/Patrick D. McPherson/
`
`505 9th Street, Suite 1000
`Washington, DC 20004
`
`202-776-7800
`
`
`
`
` Patrick D. McPherson
`Attorney for Petitioner Metrics, Inc.
`Registration No. 46,255
`
`
`
`
`
`
`
`DM2\5092045.1
`
`4
`
`
`
`
`
`CERTIFICATION OF SERVICE ON PATENT OWNER
`
`Pursuant to 37 C.F.R. §§ 42.6(e), 42.8(b)(4) and 42.105, the undersigned
`
`certifies that on the 4th day of September 2014, a complete copy of the foregoing
`
`Petitioner’s Revised Mandatory Notices Under 37 C.F.R. § 42.8 were served via e-
`
`mail on counsel for Patent Owner at:
`
`
`
`
`
`
`
`
`
`
`
`
`M. Andrew Holtman
`Andy.Holtman@finnegan.com
`Jonathan R.K. Stroud
`Jonathan.Stroud@finnegan.com
`Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`
`
`
`
`
` By: /Josh Staples /
`
`Josh Staples
`
`Duane Morris LLP
`505 9th Street, N.W., Suite 1000
`Washington, D.C. 20004
`(202) 776-7800
`
`
`
`
`
`
`DM2\5092045.1
`
`5
`
`